Search for Clinical Trial Results

Sponsored By

Carcinoma, Large Cell - 21 Studies Found

Status Study
Completed Study Name: ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures
Condition: Non-Small-Cell Lung Carcinoma
Date: 2006-11-28
Interventions:
  • Drug: ZD6474 (vandetanib) once
Completed Study Name: An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
Condition:
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasm

Date: 2003-02-12
Interventions: Biological: EP2101
Withdrawn Study Name: Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell-Lung
Date: 2012-07-06
Interventions: Drug: Temoporfin A single dose of 0.04 mg per kilogram of body weight of Temoporfin will be administered
Available Study Name: An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
Condition:
  • Non-small Cell Lung Cancer
  • Lung Cancer
  • Advanced Malignanci
    Date: 2016-05-24
    Interventions: Drug: Brigatinib Brigatinib will be administered orally to eligible patients with locally advanced or me
Completed Study Name: ALTA-1L Study: A Phase 3 Study of Brigatinib Versus Crizotinib in ALK-positive Advanced Non-Small Cell Lung Cancer Patients
Condition:
  • Non-small Cell Lung Cancer
  • Lung Cancer
  • Advanced Malignanci
    Date: 2016-03-30
    Interventions:
    • Drug: Brigatinib Brigatinib wi
Active, not recruiting Study Name: A Phase 2, Multicenter, Randomized Study of AP26113
Condition:
  • Non-small Cell Lung Cancer
  • Lung Cancer
  • Advanced Malignanci
    Date: 2014-03-18
    Interventions:
    • Drug: AP26113 90 mg tablet, ta
Not yet recruiting Study Name: Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I or Isolated Lung Parenchymal Recurrent Non-small Cell Lung Cancer: I-SABR
Condition:
  • Malignant Neoplasms of Respiratory and Intrathoracic Organs
  • Non-small Cell Lung Cancer

    • Date: 2017-04-07
    Interventions:
    • Radiation: Stereotactic Ablative Radiotherapy

Terminated Study Name: Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)
Condition: Non-small-cell Lung Cancer
Date: 2012-01-12
Interventions:
  • Radiation: SBRT (stereotactic body radiotherapy)

Terminated Study Name: Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Carcinoma
Date: 2006-08-15
Interventions: Drug: Motexafin gadolinium and pemetrexed 1 dose of MGd 15 mg/kg and pemetrexed 500 mg/m2 once during th
Completed Study Name: A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
Condition:
  • Non-Small-Cell Lung Carcinoma
  • Carcinoma, Bronchogenic

Date: 2005-01-29
Interventions: Drug: Motexafin Gadolinium Injection
<<< Previous | Next >>>